DELAWARE, Ohio, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Franchise Group, Inc. FRG ("Franchise Group" or the "Company") today announced that it will participate in small group meetings at the following investor conferences: November 15, 2022 - …
Q3 Total Revenue Increased 11% Year-over-Year to $88.4 million Q3 Gross Merchandise Value Increased 7% Year-over-Year to $475.6 million Q3 Adjusted EBITDA was ($8.0) million with (9.0%) margins REDWOOD CITY, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- …
Singapore, Nov. 10, 2022 (GLOBE NEWSWIRE) -- 8i Acquisition 2 Corp. LAX the "Company"))), a special purpose acquisition company, announced today that all proposals presented to shareholders at the special meeting of shareholders held on November …
Q2 total revenues of $102.2 million, up 29% year-over-year Q2 operating cash flow of $39.5 million, up 106% year-over-year Q2 free cash flow of $37.7 million, up 109% year-over-year Doximity, Inc. DOCS, the leading digital platform for U.S. medical …
NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Silver Spike Investment Corp. ("Silver Spike" or the "Company"), a specialty finance company that was formed to invest across the cannabis ecosystem through investments in the form of direct …
Delivers Record Revenue Growth and Significant Margin Improvement Raises 2022 Full Year Guidance for both Revenue and Adjusted EBITDA SAN FRANCISCO, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Wag! Group Co. ((the ", Company" or "Wag!", NASDAQ: …
IND clearance received for pan-BD BET inhibitor, VYN201; Anticipate first patient to be enrolled in Phase 1a/b trial for Vitiligo this month Continued progression of discovery and development of oral, BD2 selective VYN202 program Expanded analysis of …
HAMPTON, N.J., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. CLDX today announced that management will participate in fireside chats at the following investor conferences in November: Guggenheim 4th Annual Immunology and Neurology Conference …
FREMONT, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Aehr Test Systems (NASDAQ: AEHR), a worldwide supplier of semiconductor test and reliability qualification equipment, today announced that it will participate in the Craig-Hallum 13th Annual Alpha Select …
紐約, Nov. 11, 2022 (GLOBE NEWSWIRE) -- 事因： 全球投資者權益律師事務所 Rosen Law Firm 宣布代表於 2019 年 2 月 21 日至 2022 年 10 月 11 日期間（包括起止兩日，以下稱為「集體訴訟期」）購買 Enviva Inc.（NYSE：EVA）證券的人士提出集體訴訟。此集體訴訟案經已提出。若您希望擔任原告代表，請務必於 2023 年 1 月 3 日之前向法院申請。 影響性：倘若您在集體訴訟期內曾購買 Enviva 證 …
- On Track for Updates on pheEDIT and juMPStart Programs by Year-End - - Strong Financial Position with Cash Runway into Fourth Quarter 2024 - - Promoted Albert Seymour, Ph.D., to Chief Executive Officer Driving Clinical Trials and Genetic Medicines …
Today’s Funding Will Add Another 1,459 Affordable Rental Units in PA Governor Tom Wolf today announced awards totaling more than $44.2 million in Low Income Housing Tax Credits, more than $9 million in PennHOMES funding, and more than $20 million in …
NEWS RELEASE For Immediate Release: November 10, 2022 JACKSON, Miss. – Today, the State Board of Education awarded $15,450,000 in grants to 11 school districts to implement new State Invested Pre-K (SIP) programs. During the 2022 legislative session, the …
SOUTH SAN FRANCISCO, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company dedicated to developing curative cell therapies for patients with solid tumors, announced today that …
Cash, cash equivalents and investments of $262.1 million as of September 30, 2022; cash runway expected to fund operations into mid-2024 SAN FRANCISCO and SAN DIEGO, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a …
VANCOUVER and MINNEAPOLIS, Nov. 10, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today reported financial results for the third quarter ended September 30, 2022. Recent Highlights Generated …
– End of third quarter cash position of $90.7 million excludes the recent $50 million registered offering, and together, provide a cash runway into 2025 – – Phase 3 pivotal MANTRA trial topline data now anticipated in first quarter of 2023 – – Phase 2 …
Received Orphan Drug Designation for enitociclib; continue to focus on priority indications IND submission for first-in-class small molecule drug conjugate (SMDC) VIP236 expected by year-end IND filings for antibody drug conjugates (ADCs), VIP943 and …
Third Quarter 2022 Revenue Increased 25% Year-Over-Year to $2.4 Million Company Rolls Out New Product Extension with Twist & Go™ Carton Format Company Pursues Legal Action Against a Bottle Manufacturer of Twist & Go™ LOS ANGELES, Nov. 10, 2022 ( …
RICHLAND, Wash., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, today announced its financial results for the …
01 days 10:16:53
